Ledeninformatie
Dr Yannick Lemer
Frankrijk
Team
Dr Catherine Vignal-Clermont
Frankrijk
HCP-centrum
contact
Fondation Adolphe de Rothschild, Paris, France
Klinische proeven
Precise High Resolution MRI to Increase Accuracy and Gain Confidence to Diagnose Patients With Optic Disc Edema (PAGODE)
RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry
Spontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept Injections
Interest of Intravitreal Injections of Anti-VEGF as Initial and Adjuvant Treatment in Coats Disease.
Prospective Analysis of «Genotype-phenotype» Correlations Observed in a LargeCohort of Patients With Hereditary Retinal Dystrophies - GEPHIRD
Historical Case Record Survey of Visual Acuity Data From Patients With Leber’s Hereditary Optic Neuropathy (LHON).
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
Evaluation of safety and efficacy of r-hNGF in patients with stage 2 and 3 Neurotrophic Keratitis (REPARO).
European Disease Registry on Retinopathy of Prematurity (ROP)